Cell Therapy in Patients With Chronic Ischemic Heart Disease Undergoing Cardiac Surgery

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
This prospective, randomized, placebo-controlled study was designed to assess the safety, feasibility and efficacy of intramyocardial injection of autologous bone marrow mononuclear cells in patients with severe, chronic ischemic disease scheduled to coronary artery bypass surgery.
Epistemonikos ID: b45745078899bf86be76a9727cb2984f43d99e66
First added on: May 06, 2024